Improving Diagnostic Quality in Upper Gastrointestinal Endoscopy in Viet Nam: Mucosal Visualization, Structured Reporting and Performance Measurement

MEASUREMENT, LEARNING & IMPROVEMENTDIAGNOSTIC SAFETY & RISK MANAGEMENT

11/5/202626 min read

Improving Diagnostic Quality in Upper Gastrointestinal Endoscopy in Viet Nam: Mucosal Visualization, Structured Reporting and Performance Measurement

A report stating that an upper gastrointestinal endoscopy was normal can be reassuring. But how much confidence should clinicians and patients place in that conclusion?

The endoscope may have reached the duodenum, the procedure may have been completed without complications, and several photographs may have been saved. Yet the reliability of the diagnostic assessment also depends on whether the relevant mucosal surfaces were adequately visualized, whether important abnormalities were recognized, and whether technical limitations affected the examination.

A small lesion may be difficult to identify when mucus, bubbles, residual food, or inadequate distension obscure the mucosa. An abnormality may be observed but described too vaguely to guide subsequent assessment. A technically complete examination may also be difficult to review retrospectively when important anatomical landmarks or abnormal findings were not documented.

These concerns do not mean that every lesion identified during a later examination was necessarily missed earlier. Disease may develop or change between procedures, and some abnormalities remain difficult to recognize despite an appropriate examination. Nevertheless, differences in mucosal inspection, lesion characterization, and reporting can influence the reliability of diagnostic information.

Upper gastrointestinal (UGI) endoscopy, also known as esophagogastroduodenoscopy (EGD), is widely used to evaluate conditions affecting the esophagus, stomach, and duodenum. Its ability to directly visualize the mucosa and obtain tissue samples when indicated makes it an important diagnostic procedure. Completing the procedure, however, is not necessarily equivalent to performing a diagnostically adequate examination.

Recent international guidance has brought renewed attention to this distinction. In September 2025, the European Society of Gastrointestinal Endoscopy (ESGE) published updated performance measures for upper gastrointestinal endoscopy, addressing appropriate indications, mucosal visibility, photodocumentation, examination time, standardized terminology, selected biopsy protocols, and surveillance quality.

The ESGE also published its STAndardization of Reports (STAR) Project in August 2025, proposing a consistent structure for documenting upper gastrointestinal examinations. In April 2026, the British Society of Gastroenterology (BSG) and the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) published further best-practice guidance emphasizing systematic mucosal inspection, appropriate visualization techniques, recognition of early lesions, and reliable reporting.

Together with the MAPS III guideline published in 2025 and earlier recommendations from the American Gastroenterological Association (AGA), these publications provide a useful foundation for improving diagnostic endoscopy quality.

For healthcare organizations in Viet Nam, the priority is not simply to increase the number of examinations, photographs, or biopsies performed. It is to ensure that each procedure is appropriate for its clinical purpose, produces sufficiently reliable visual information, and generates a report that supports informed clinical decisions.

What Makes an Upper Gastrointestinal Endoscopy Diagnostically Reliable?

Technical completion is an important procedural milestone. For a routine comprehensive diagnostic upper gastrointestinal examination, this generally involves appropriate assessment of the esophagus, stomach, and duodenum. Reaching the intended anatomical endpoint, however, does not independently establish that every relevant mucosal surface was adequately inspected.

Diagnostic reliability begins with the clinical indication. The examination should address a sufficiently clear question, whether that involves investigating symptoms, evaluating a previously identified abnormality, assessing suspected disease, or undertaking surveillance in selected circumstances.

Adequate visualization is equally important. The endoscopist needs a sufficiently clear view of the relevant mucosa to assess abnormalities within the intended scope. Small, flat, or subtle lesions may be particularly difficult to recognize when visibility is impaired.

Recognition and characterization are separate but closely connected responsibilities. Identifying an abnormality is only part of the diagnostic process. Its location, appearance, extent, and other clinically relevant features may need to be described accurately to support interpretation and subsequent care.

Documentation connects the examination with the wider clinical pathway. Another appropriately qualified professional should be able to understand what was examined, what was found, and whether technical or anatomical limitations affected the conclusions.

These aspects of quality are connected, but they cannot substitute for one another. An examination may reach the duodenum while visibility in parts of the stomach remains limited. Another may produce excellent photographs but describe an abnormality without sufficient anatomical detail. A report may contain every expected field while still be misleading if automatically generated normal findings do not reflect what the endoscopist actually observed.

A high-quality examination should therefore provide more than evidence that the endoscope was inserted and withdrawn successfully. It should produce a clinically meaningful assessment within its intended scope, supported by accurate documentation and an appropriate understanding of any remaining uncertainty.

Appropriate Indications and Preparation Before Endoscopy

Diagnostic quality begins before the endoscope is introduced. The clinical indication influences how the examination should be planned, what information needs to be reviewed, and which findings may require particular attention.

An examination requested for unexplained swallowing difficulty may involve different diagnostic considerations from surveillance of a previously established precancerous condition. Similarly, assessment of a suspected bleeding source may require a different approach from routine evaluation of persistent upper gastrointestinal symptoms.

The ESGE 2025 performance measures identify appropriate indication as a key quality measure. Avoiding unnecessary examinations matters because endoscopy involves procedural risks and uses clinical resources that could otherwise support patients with stronger indications.

However, an indication that falls outside a commonly accepted list does not automatically establish inappropriate care. Individual circumstances may justify an examination when the clinical reasoning is adequately supported and documented.

For healthcare organizations, an important improvement opportunity is ensuring that the reason for endoscopy is sufficiently clear for the endoscopist to understand the diagnostic question. Previous endoscopy reports, pathology findings, relevant medical history, medication information, and other investigations may influence the examination plan.

Preparation also affects diagnostic reliability. Residual food, secretions, or other material may obscure the mucosa and prevent adequate inspection. Appropriate preparation helps reduce these limitations while supporting patient safety.

The ESGE 2025 guidance includes fasting instructions among its key performance measures. For eligible routine examinations, it describes fasting for at least two hours for clear liquids and six hours for solid food. These intervals should not be interpreted as universal instructions for every patient or clinical situation.

Preparation requirements may vary according to the patient's condition, aspiration risk, urgency, sedation plan, and applicable professional guidance. In an emergency, delaying an examination solely to satisfy routine fasting intervals may be inappropriate. Conversely, proceeding without adequate consideration of aspiration risk may expose the patient to avoidable harm.

The responsible clinical team must determine the appropriate approach.

Informed consent is another essential consideration. Patients should receive information appropriate to the examination, including its purpose, anticipated benefits, relevant risks, reasonable alternatives, and the possibility that additional procedures or tissue sampling may be necessary.

From a diagnostic quality perspective, the priority is to ensure that the examination is justified, appropriately planned, and performed under conditions that support both reliable visualization and patient safety.

Mucosal Visualization and Systematic Inspection

Direct visualization is the principal diagnostic advantage of upper gastrointestinal endoscopy. Its reliability depends on whether the relevant mucosal surfaces can be inspected adequately.

Mucus, bubbles, residual fluid, food material, blood, or insufficient distension may obscure important details. These limitations can be particularly consequential when assessing small or flat abnormalities.

Early neoplastic changes do not always appear as obvious masses or ulcers. Some produce relatively subtle differences in mucosal color, surface pattern, or vascular appearance. Recognizing such findings requires appropriate equipment, adequate visibility, and careful professional inspection.

The ESGE 2025 update identifies documentation of mucosal visibility using a standardized, validated scale as a key performance measure.

Examples include the Gastroscopy Rate of Cleanliness Evaluation (GRACE), the Polprep Effective Assessment of Cleanliness in Esophagogastroduodenoscopy (PEACE) scale, and the Barcelona cleanliness scale.

These tools provide a more consistent way to describe mucosal cleanliness and visibility across examinations and endoscopists. Their value lies in distinguishing examinations with adequate visual conditions from those in which obscured mucosa may limit diagnostic confidence.

However, a favorable visibility score does not guarantee that every important lesion was recognized. An adequately cleaned mucosa may still contain subtle findings requiring expert interpretation. Conversely, a technically difficult examination may provide sufficient information to answer a specific clinical question despite limitations in other areas.

Visibility scores should therefore support professional judgment rather than replace it.

The BSG/AUGIS guidance published in April 2026 emphasizes mucosal cleansing, systematic inspection, and appropriate use of enhanced visualization techniques.

Depending on the examination and patient circumstances, visibility may be improved through irrigation, removal of obscuring material, appropriate insufflation, or other professionally indicated measures.

Some services also use mucolytic or defoaming agents as part of established preparation protocols. Their selection and administration require consideration of the patient's condition, relevant contraindications, aspiration risk, manufacturer instructions, and institutional procedures.

No single preparation or cleansing method should be assumed appropriate for every patient.

Equipment also influences visualization. High-definition white-light endoscopy and image-enhancement technologies can improve the assessment of selected abnormalities when used appropriately. Nevertheless, access to advanced equipment does not replace systematic inspection or professional competence.

For quality improvement, the important questions are whether visibility was sufficient for the intended diagnostic purpose, whether appropriate steps were taken when it was inadequate, and whether any remaining limitations were documented.

A report describing an examination as normal without acknowledging materially obscured areas may convey more certainty than the visual evidence supports.

When visualization remains inadequate, the responsible clinician should determine whether the examination has answered the intended question or whether further assessment is justified. Depending on the circumstances, this may involve repeat endoscopy or another appropriate diagnostic approach.

Systematic anatomical inspection is equally important. The BSG/AUGIS guidance emphasizes a structured assessment of the esophagus, stomach, and duodenum. In the stomach, forward and retroflexed views provide complementary opportunities to examine areas that may be difficult to assess from a single perspective.

A systematic approach reduces reliance on an unstructured visual search and helps ensure that relevant anatomical regions receive appropriate attention.

However, systematic inspection should not become an inflexible requirement to perform every maneuver regardless of clinical circumstances. Emergency procedures, examinations directed toward a specific known abnormality, procedures terminated because of patient intolerance, and examinations involving surgically altered anatomy may require different approaches.

The intended scope and any limitations should be documented accurately.

A focused examination should not automatically be classified as poor quality because it does not include every component of a comprehensive examination. Equally, a routine diagnostic endoscopy should not be considered complete simply because the endoscope reached the intended endpoint.

Completeness must reflect both the clinical purpose and the quality of the inspection actually performed.

Examination Time: A Useful Indicator With Important Limitations

The time available for endoscopy can influence the opportunity for careful mucosal inspection.

A very short examination may leave insufficient time to assess subtle abnormalities, clean obscured areas, or document findings adequately. At the same time, a longer procedure does not necessarily produce better diagnostic information.

The ESGE 2025 update identifies an examination duration of at least seven minutes as a key performance measure for eligible diagnostic upper gastrointestinal endoscopies.

Importantly, this interval is measured from insertion of the endoscope to its removal. It should not be described as seven minutes devoted exclusively to examining the stomach or as a universal requirement for every endoscopic procedure.

The guidance also proposes allocating a time slot of at least 20 minutes for diagnostic upper gastrointestinal endoscopy. This is a separate, minor performance measure related to scheduling.

The allocated procedural time and the actual interval between endoscope insertion and removal are different measurements and should not be treated as equivalent.

The ESGE guidance identifies exclusions that affect how examination duration should be assessed. Emergency and therapeutic procedures, deliberately limited examinations, procedures terminated early for safety or patient intolerance, and examinations affected by substantially altered anatomy may require different consideration.

These distinctions matter when comparing departments or individual endoscopists.

A service caring for patients with complex conditions may have examination durations that differ from those in a routine outpatient diagnostic unit. Such variation should not automatically be interpreted as evidence of better or worse quality.

The purpose of monitoring examination time is to establish whether the clinical environment provides a reasonable opportunity for adequate inspection.

A service that routinely schedules examinations too tightly may create pressures that make careful observation, cleansing, and documentation more difficult. Improvement may therefore require attention to appointment scheduling, staffing, equipment availability, and workflow design rather than simply instructing endoscopists to spend more time on every procedure.

Examination duration is most useful when interpreted alongside mucosal visibility, anatomical coverage, image documentation, patient tolerance, and the clinical indication.

Photodocumentation: Making the Examination Reviewable

Written reports communicate the endoscopist's findings, while stored images provide additional evidence of the examination.

Photodocumentation can support identification of anatomical landmarks, characterization of abnormalities, comparison with previous examinations, and retrospective quality review.

The ESGE 2025 update identifies accurate photodocumentation of relevant normal anatomical landmarks and abnormal findings as a key performance measure.

For eligible routine diagnostic examinations, ESGE maintains its recommendation for at least 10 representative photographs of specified anatomical landmarks, together with images of any lesions or abnormal findings.

The proposed documentation includes three esophageal views, five gastric views, and two duodenal views. These cover the proximal and distal esophagus, the Z-line and diaphragmatic indentation, important regions of the stomach, the duodenal bulb, and the second part of the duodenum.

The recommendation provides a useful reference for systematic image documentation. It should not, however, be interpreted as a universal Vietnamese legal requirement or a guarantee of diagnostic completeness.

The objective is to preserve a meaningful record of the examination rather than accumulate the largest possible number of photographs.

A collection of images may contain repeated views of the same anatomical region while omitting an important landmark. An abnormality may also be photographed without sufficient information about its location, extent, or relevant features.

Where a lesion is identified, documentation may need to include its anatomical location, approximate size, morphology, and other characteristics relevant to the clinical assessment.

The written report should make the relationship between stored images and the described findings understandable.

When no abnormality is identified, documentation should still provide an appropriate record of the examination's relevant anatomical coverage.

However, photographs represent selected moments in a dynamic procedure. Their presence does not independently establish that every mucosal surface was adequately examined.

Similarly, the absence of a particular photograph may indicate a documentation deficiency without proving that the corresponding anatomical region was never inspected.

Quality reviewers should therefore distinguish incomplete photodocumentation from confirmed deficiencies in examination performance. The two problems may overlap, but they require different evidence.

Image identification, storage, and retrieval also matter.

A technically appropriate examination may be difficult to review if images are not correctly associated with the patient, are stored under an incorrect identifier, or cannot be accessed when needed.

Healthcare organizations should treat image traceability and authorized access as components of the endoscopy quality system, not merely as information technology functions.

Structured Reporting and Standardized Terminology

Endoscopy reporting practices can vary considerably between clinicians and healthcare organizations.

One report may contain detailed descriptions of relevant anatomical structures and abnormalities, while another provides only a brief conclusion. Both may be understandable to the original endoscopist, but inconsistent reporting can make subsequent clinical communication, comparison with previous examinations, and quality assessment more difficult.

The ESGE STAndardization of Reports (STAR) Project, published in August 2025, proposes a structured approach to upper gastrointestinal endoscopy reporting.

Its framework addresses information before, during, and after the examination.

Preprocedural information includes patient identification, the indication, relevant clinical circumstances, preparation, and other details necessary to understand the procedure.

Periprocedural information includes the equipment used, relevant medications or sedation, and assessment of mucosal cleanliness. The findings section describes the esophagus, stomach, and duodenum, including abnormalities identified during the examination.

Postprocedural information may include tissue sampling, specimen containers, stored images, examination duration, and other relevant details.

A standardized structure can help ensure that important information is not omitted simply because individual endoscopists use different reporting habits.

However, structured reporting should not be confused with automatically generated text.

A report may contain every expected field while remaining clinically misleading if its content does not reflect what was actually observed. For example, an automatically inserted statement describing the stomach as normal may be inappropriate when part of the mucosa was not adequately visualized.

The quality of reporting depends on whether the information is accurate, sufficiently specific, and relevant to the clinical question.

Standardized terminology contributes to this reliability.

The ESGE 2025 performance measures identify appropriate use of validated disease-related terminology and classifications as a key quality indicator.

The Los Angeles classification is widely used to describe reflux esophagitis. The Prague classification supports documentation of the extent of Barrett's esophagus when relevant. The Paris classification provides standardized terminology for the morphology of superficial gastrointestinal lesions.

For selected gastric conditions, validated classifications concerning atrophy or intestinal metaplasia may also be appropriate.

These systems address different clinical questions and should not be applied indiscriminately.

A classification is useful when it accurately represents the observed finding and supports interpretation or management. Adding classification labels simply to make a report appear more complete may introduce confusion when the labels do not correspond to the actual abnormality.

Personnel require appropriate training to apply relevant terminology consistently, and reporting systems should support accurate descriptions without encouraging unsupported conclusions.

Endoscopic appearance and histopathological diagnosis must also be distinguished when tissue confirmation is necessary. A visually suspected condition should not automatically be presented as a definitive histopathological diagnosis.

The BSG/AUGIS 2026 guidance similarly emphasizes documenting the extent of examination, reasons for incompleteness, mucosal visibility, relevant abnormalities, and technical limitations.

A useful report should allow another clinician to understand what was examined, what was found, what remains uncertain, and how confidently the procedure addressed the original diagnostic question.

This becomes particularly important when patients are referred between facilities or require subsequent assessment elsewhere.

Biopsy Quality and the Connection With Histopathology

Upper gastrointestinal endoscopy allows direct visualization of the mucosa and, when clinically indicated, tissue sampling for histopathological assessment.

The reliability of this process depends on appropriate decisions about whether tissue is required, where samples should be obtained, and how their anatomical origin and clinical context are communicated.

Not every visible abnormality requires biopsy, and not every examination justifies routine sampling of normal-appearing mucosa.

Conversely, some conditions require tissue assessment even when endoscopic abnormalities are subtle or absent.

The appropriate approach depends on the suspected condition, relevant clinical findings, and applicable professional guidance.

The ESGE 2025 performance measures address biopsy quality in selected disease-specific situations.

For surveillance of nondysplastic Barrett's esophagus, adherence to the relevant Seattle biopsy protocol is identified as a key performance measure. The guidance also includes a separate, minor measure concerning observation time and chromoendoscopy during appropriate Barrett's surveillance examinations.

For patients undergoing evaluation of gastric precancerous conditions, the ESGE framework refers to recommendations in the Management of Epithelial Precancerous Conditions and Early Neoplasia of the Stomach guidelines.

The updated MAPS III guideline, published in March 2025, emphasizes high-quality endoscopic examination, appropriate use of image-enhancement techniques, characterization of relevant gastric abnormalities, and tissue sampling when indicated for diagnosis or risk assessment.

Its recommendations depend on the patient's findings, clinical purpose, and relevant risk factors. They should not be simplified into a requirement that every patient undergoing upper gastrointestinal endoscopy receive the same number or pattern of biopsies.

When tissue sampling is indicated, accurate identification of specimen origin is important.

Specimens from different anatomical sites may need to be placed in appropriately labeled containers according to the relevant diagnostic protocol. This information helps pathology professionals interpret the material within the intended clinical context.

The endoscopy report should document relevant sampling details, including the sites from which specimens were obtained.

Where histopathological findings are subsequently available, the responsible clinical team should interpret them alongside the endoscopic findings and the patient's circumstances.

A completed biopsy does not necessarily mean that the diagnostic evaluation is complete.

Where important differences arise between endoscopic and histopathological findings, further professional review may be appropriate. Such differences should be investigated according to the available evidence rather than assuming that disagreement automatically establishes an error in either specialty.

Quality improvement should also avoid using biopsy volume as a simplistic indicator of good care.

Increasing the number of samples may add pathology workload, costs, and procedural interventions without necessarily improving diagnostic value. On the other hand, inadequate sampling when tissue assessment is indicated can reduce diagnostic reliability.

The objective is appropriate sampling for the clinical question, not maximizing the number of biopsies.

This distinction matters when calculating performance measures. An indicator concerning adherence to a specified biopsy protocol should include only examinations for which that protocol is applicable.

For diagnostic quality, the essential connection is between what was visualized, what was sampled, what was reported, and what the combined findings can reasonably establish.

Patient Safety and Experience in Diagnostic Endoscopy

Diagnostic quality cannot be separated entirely from the circumstances in which an examination is performed.

An endoscopic assessment may be technically possible but difficult to complete adequately because the patient experiences significant discomfort or cannot tolerate the procedure.

Patient preparation, local anesthesia, sedation when appropriate, clinical monitoring, infection prevention, and equipment safety can all influence the conditions under which endoscopy takes place.

These activities involve patient-specific decisions that must reflect clinical risk, patient preferences, professional responsibilities, and the capabilities of the healthcare service.

The BSG/AUGIS 2026 guidance recognizes the contribution of appropriate patient preparation, comfort measures, sedation when indicated, mucosal cleansing, and monitoring to high-quality examinations.

This does not imply that every patient should receive the same sedation regimen or that additional sedation necessarily improves diagnostic quality.

Patient tolerance should also be considered when interpreting examination completeness.

If a procedure is stopped early because of safety concerns or intolerance, this may represent an appropriate professional decision rather than poor-quality care. The resulting examination may be incomplete, but the limitation should be documented so that the responsible clinician can determine whether further assessment is necessary.

Patient-reported experience is included in the ESGE 2025 performance framework.

A patient-centered endoscopy service should consider whether individuals receive understandable information, have an opportunity to raise concerns, and experience care that respects their dignity and needs.

Patient satisfaction, however, does not independently establish diagnostic accuracy.

A person may report an excellent procedural experience even when technical limitations affected the examination. Conversely, an uncomfortable procedure may still provide clinically valuable diagnostic information.

Patient experience and diagnostic performance are complementary but distinct aspects of quality.

Infection prevention and endoscope reprocessing are additional essential safety responsibilities. They require appropriate equipment, documented procedures, trained personnel, and adherence to applicable regulatory and professional requirements.

Although detailed endoscope reprocessing falls outside the principal scope of this article, a reliable diagnostic endoscopy service depends on effective infection prevention and equipment safety systems.

Measuring Upper Gastrointestinal Endoscopy Performance

The ESGE 2025 update provides a structured framework for measuring quality in upper gastrointestinal endoscopy.

The working group identified 15 performance measures, comprising 11 key measures and four minor measures.

The key measures address several stages of care, including appropriate indications, fasting instructions, documented mucosal visibility, accurate photodocumentation, examination time, standardized terminology, selected disease-specific biopsy protocols, documentation of complications after therapeutic procedures, and appropriate surveillance of selected precancerous conditions.

The minor measures concern allocated examination time, selected inspection practices for particular higher-risk groups, and patient-reported experience.

These indicators are not all intended for the same examination population.

For many service-level measures, ESGE proposes annual assessment using a sample of 100 consecutive eligible upper gastrointestinal endoscopies.

The eligibility criteria and exclusions are important.

Emergency and therapeutic procedures, deliberately focused examinations, procedures terminated early because of patient intolerance or safety concerns, and examinations involving substantially altered anatomy should not automatically be included in the same denominator as routine comprehensive diagnostic examinations.

Some indicators also require separate populations.

Measures concerning complications after therapeutic procedures should be assessed among the relevant therapeutic examinations rather than calculated across all routine diagnostic procedures.

Similarly, surveillance-related indicators should be applied only to patients and examinations for which the relevant surveillance recommendations are appropriate.

For many measures, ESGE proposes a minimum performance standard of at least 90% and a target of at least 95%.

These benchmarks were developed through expert consensus and appraisal of the available evidence.

Importantly, the ESGE authors acknowledge that the quality of evidence supporting many performance measures remains low.

The thresholds can therefore provide useful reference points for improvement, but they should not be presented as universally validated predictors of patient outcomes or mandatory national performance standards in Viet Nam.

Healthcare organizations should assess their relevance to local services, patient populations, resources, and applicable professional requirements.

Quality measurement also depends on accurate definitions and denominators.

A low proportion of examinations meeting the seven-minute duration measure may indicate scheduling or workflow problems in a routine diagnostic service. The same proportion may have a different meaning if emergency procedures or deliberately limited examinations were incorrectly included.

Similarly, a high rate of photodocumentation may reflect good reporting compliance without establishing that subtle abnormalities were consistently recognized.

The value of a quality framework lies in identifying clinically meaningful variation, supporting professional review, and assessing whether improvement interventions have addressed the underlying problems.

Interpreting Performance Without Reducing Quality to a Score

Performance measures make aspects of clinical quality visible, but they cannot replace professional judgment.

A department may achieve high compliance with photodocumentation requirements while still experiencing variation in lesion recognition. Another may consistently record examination duration but provide insufficient information about mucosal visibility.

A completed reporting template does not automatically prove that the mucosa was adequately inspected or that important abnormalities were identified.

Diagnostic yield also requires careful interpretation.

The number of abnormalities detected can be influenced by the patient population, clinical indication, disease prevalence, previous investigations, and referral patterns.

An endoscopist working primarily with higher-risk patients may detect more abnormalities than one performing routine examinations in a lower-risk population.

This difference should not automatically be interpreted as superior technical performance.

A balanced quality program should therefore combine relevant process indicators with selected professional review of clinical findings, documentation, and outcomes.

Healthcare organizations may examine mucosal visibility scores, completeness of image documentation, consistency of terminology, adherence to relevant protocols, and reporting of technical limitations.

Selected cases may also require review when important discrepancies, unexpected later findings, or concerns about examination quality arise.

However, a serious diagnosis made after a previous endoscopy does not automatically establish that an earlier lesion was missed.

Disease may have developed in the interval, changed in appearance, or been difficult to recognize at the earlier stage.

Retrospective review should consider the original clinical indication, available images, documented visibility, technical limitations, and information reasonably available at the time.

The purpose is to identify potentially missed opportunities for improvement while recognizing the inherent limitations of diagnostic examination.

This approach supports learning without treating every unfavorable clinical outcome as proof of professional error.

Competence, Leadership, and Effective Quality Review

High-quality upper gastrointestinal endoscopy depends on both individual professional competence and the organizational environment.

Endoscopists require appropriate technical and interpretive skills, including systematic mucosal inspection and recognition of clinically meaningful abnormalities.

However, professional competence alone cannot compensate for inadequate equipment, unrealistic scheduling, inconsistent preparation, or unreliable reporting systems.

Healthcare organizations should therefore establish clear responsibilities for endoscopy quality.

Clinical leadership should oversee relevant professional protocols, authorized practice, competence assessment, and appropriate review of examination quality.

Nursing and other endoscopy personnel contribute to preparation, procedural coordination, monitoring, documentation, and patient safety within their authorized responsibilities.

Quality management personnel may support indicator development, audit design, incident review, and evaluation of improvement activities. Information technology teams may be needed to maintain reporting systems, image storage, and reliable extraction of quality data.

These responsibilities should be coordinated rather than managed as isolated tasks.

An endoscopy service may have well-trained professionals but still struggle to provide dependable examinations when appointment schedules do not allow sufficient time for careful inspection.

Similarly, acquiring high-definition equipment may offer limited benefit if the organization does not establish the training and workflows needed to use it effectively.

Quality review should examine these relationships.

A practical audit can begin with a representative group of eligible diagnostic examinations and determine whether important information has been recorded.

This may include the clinical indication, mucosal visibility, anatomical coverage, relevant images, examination duration, standardized terminology, and reporting of limitations.

Where tissue sampling was indicated, the review may also examine whether biopsy information was documented appropriately.

Administrative review and clinical peer review serve different purposes.

An administrative audit may establish whether required documentation is present. It cannot independently determine whether a subtle mucosal abnormality was interpreted correctly.

Selected cases may therefore require review by appropriately qualified professionals.

The process should be sufficiently structured to promote consistency while allowing reviewers to recognize differences in clinical circumstances.

When concerns arise, the organization should determine whether they represent isolated events or recurring problems.

Repeated poor visualization may suggest weaknesses in preparation or cleansing arrangements. Inconsistent photodocumentation may reflect inadequate protocols or difficulties using the reporting system. Missing examination duration data may indicate an information-system limitation rather than a problem with the endoscopist's clinical performance.

The response should address the underlying cause.

Quality improvement may require changes in scheduling, staff training, equipment availability, reporting templates, or clinical workflow. Adding another documentation field does not necessarily improve the examination itself.

The organization should reassess performance after implementing changes and determine whether the intended improvement has occurred.

Applying International Endoscopy Guidance in Viet Nam

Upper gastrointestinal endoscopy services in Viet Nam are provided across public and private hospitals, specialized facilities, and other appropriately authorized healthcare settings.

These organizations differ in patient populations, procedure volumes, equipment, staffing, specialist capabilities, and information systems.

Quality management arrangements should reflect these differences while maintaining the fundamental principles of safe and reliable diagnostic care.

The Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides the broader legal framework governing medical examination, treatment, professional responsibilities, and healthcare facility activities.

Healthcare organizations must operate within their applicable licensing arrangements and authorized professional scope. Endoscopic procedures should be undertaken by appropriately qualified and authorized professionals in accordance with relevant technical and organizational requirements.

Another important reference is Circular No. 23/2024/TT-BYT, issued by the Ministry of Health on October 18, 2024, concerning the list of medical examination and treatment techniques.

The circular was amended by Circular No. 25/2026/TT-BYT, issued on June 30, 2026.

Although Circular No. 25/2026/TT-BYT generally took effect on August 15, 2026, its Article 3 amendments concerning the medical examination and treatment technique lists took effect earlier, on July 1, 2026.

The consolidated text is reflected in Consolidated Document No. 13/2026/VBHN-TT-BYT dated July 30, 2026. This consolidated document serves as a reference for reading the amended provisions and does not have separate legal effect from the underlying instruments.

Under the amended framework, the list of techniques in Appendix 01 continues to apply through December 31, 2027, while the revised list in Appendix 02 is scheduled to apply from January 1, 2028.

The framework also contains provisions relevant to healthcare facilities operating under previously approved professional scopes.

Healthcare organizations should consider the requirements and transitional arrangements applicable to their own licensed activities.

However, the inclusion of a technical procedure in the national list does not independently establish that an individual examination meets a particular international quality benchmark.

Authorization to perform a procedure and measurement of diagnostic quality address related but different questions.

Likewise, the ESGE 2025 performance measures, STAR reporting framework, MAPS III guideline, and BSG/AUGIS 2026 guidance are international professional resources.

They can inform quality improvement in Viet Nam, but they should not automatically be represented as legally binding requirements for every Vietnamese healthcare facility.

The BSG/AUGIS guidance itself emphasizes that its recommendations represent professional best-practice consensus and should be interpreted according to clinical circumstances and available resources. It does not establish a legal standard of care.

Healthcare organizations should distinguish applicable Vietnamese regulatory obligations from additional professional quality measures adopted through institutional policies, accreditation commitments, or voluntary improvement programs.

International benchmarks may provide useful reference points, but their implementation should account for local patients, equipment, workforce, and the types of examinations actually performed.

The aim is to adapt evidence-informed quality practices responsibly, with attention to their relevance and feasibility, rather than treating numerical thresholds as universally applicable requirements.

Medical Records, Image Documentation, and Data Protection

Endoscopy reports, stored images, biopsy information, and related records may contain important information for subsequent diagnosis, treatment, and quality review.

Article 69 of the Law on Medical Examination and Treatment establishes requirements concerning medical records, including their creation, updating, preservation, confidentiality, and access.

These provisions are relevant to how endoscopy findings and reports are maintained within healthcare organizations.

Circular No. 13/2025/TT-BYT, issued by the Ministry of Health on June 6, 2025 and effective July 21, 2025, provides guidance on the implementation of electronic medical records in healthcare facilities.

Electronic reporting systems can support structured documentation, retrieval of previous examinations, and quality assessment.

However, introducing electronic medical records does not automatically establish that endoscopy reporting is clinically complete or accurate.

Those outcomes depend on system design, appropriate data entry, professional procedures, and continuing oversight.

Healthcare organizations should establish how images are linked to the correct patient and examination, how reports are finalized, and how relevant information is made available to authorized professionals.

Personal data protection is another important consideration.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and its implementing Decree No. 356/2025/ND-CP took effect on January 1, 2026.

Endoscopy reports, clinical images, pathology information, and quality review records may contain identifiable health information and other personal data.

Healthcare organizations should assess the applicable requirements concerning lawful processing, confidentiality, authorized access, information security, disclosure, and data transfers.

Consent requirements, applicable exceptions, and other relevant legal conditions should be considered according to the purpose and circumstances of the processing activity.

Where clinical images are used for professional education, external consultation, research, or quality assessment, the organization should determine whether the intended use is permitted under the relevant legal and organizational arrangements.

The fact that an image is useful for education or quality improvement does not automatically authorize unrestricted sharing.

A dependable endoscopy quality system should preserve the information necessary for patient care and professional review while maintaining appropriate protection of patient confidentiality.

Building a Practical Quality Improvement Program

For many healthcare organizations, the most useful starting point is not a large accreditation project or an extensive new dashboard.

It is a focused assessment of whether routine upper gastrointestinal examinations are performed and documented consistently.

An endoscopy unit can begin by identifying a defined group of eligible diagnostic examinations and selecting a manageable number of meaningful indicators.

These may include documentation of mucosal visibility, completeness of examination, appropriate image capture, standardized terminology, examination duration, and reporting of clinically relevant limitations.

The indicators should reflect the service's activities and the risks identified through local review.

Appropriate exclusions must also be established. Emergency, therapeutic, deliberately focused, and prematurely terminated procedures may require separate measurement approaches.

After examining baseline performance, the unit can identify which problems deserve priority.

If mucosal visibility is frequently inadequate, preparation and cleansing arrangements may require review. If reports omit important anatomical findings or technical limitations, reporting templates and documentation practices may need improvement.

If examination times are consistently short among eligible routine procedures, scheduling and workflow arrangements may deserve attention. If stored images are incomplete, the organization should determine whether the problem concerns image capture, staff practice, equipment, or information-system limitations.

Improvement interventions should follow the findings rather than assume that every problem requires additional training or documentation.

For example, introducing a standardized visibility score may improve reporting consistency, but it will not necessarily improve actual mucosal visualization unless staff understand how to assess and respond to poor visibility.

Similarly, requiring more photographs may increase compliance with a documentation indicator without guaranteeing better lesion recognition.

The quality program should therefore assess whether changes improve the underlying diagnostic process.

Endoscopists, nursing personnel, quality managers, and relevant technical staff should contribute according to their responsibilities.

After implementing changes, the organization can repeat the review to determine whether performance has improved and whether unintended difficulties have emerged.

Selected cases may require professional assessment beyond routine administrative auditing, particularly where clinically significant concerns are identified.

The aim is to establish a sustainable learning process rather than a one-time compliance exercise.

Quality improvement becomes meaningful when the organization can demonstrate that identified weaknesses have been investigated, appropriate measures have been introduced, and the reliability of the examination process has improved.

From Procedural Completion to Diagnostic Excellence

Upper gastrointestinal endoscopy is an important diagnostic tool, but its reliability depends on more than reaching the intended anatomical endpoint or issuing a final report.

The mucosa must be visualized sufficiently for the clinical purpose. Relevant abnormalities need to be recognized and characterized. Important findings and limitations should be documented clearly, and the resulting information must support appropriate clinical decisions.

The ESGE performance measures updated in 2025, the STAR reporting project, the MAPS III guideline, and the BSG/AUGIS best-practice guidance published in 2026 provide complementary foundations for improving these activities.

They also highlight an important distinction between measurable process quality and demonstrated clinical outcomes.

A longer examination, additional photographs, or a completed reporting template may support quality, but none independently proves that every relevant abnormality has been detected.

For healthcare organizations in Viet Nam, the priority should be to establish practical systems that support careful mucosal inspection, reliable documentation, professional competence, and meaningful performance review.

These arrangements should reflect the types of procedures performed, the populations served, available resources, and applicable Vietnamese professional and legal requirements.

Quality improvement should not reward unnecessary examinations, additional biopsies without indication, or longer procedure times pursued solely to meet numerical targets.

Instead, it should help healthcare professionals establish when an examination has provided adequate diagnostic information, recognize limitations when it has not, and learn from patterns that may compromise reliable care.

Diagnostic excellence in upper gastrointestinal endoscopy is not demonstrated simply by completing a procedure. It depends on whether the relevant mucosa was adequately examined, important findings were accurately documented, and the healthcare organization can meaningfully evaluate and improve the reliability of the diagnostic information produced.

Selected References and Regulatory Sources

Areia M, Esposito G, Leclercq P, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative, Update 2025. Endoscopy. 2025;57(11):1268–1297. Published online September 11, 2025. DOI: 10.1055/a-2674-4912.

Esposito G, Areia M, Ching HL, et al. STAndardization of Reports (the STAR Project) Upper Gastrointestinal Endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2025;57(11):1298–1308. Published online August 20, 2025. DOI: 10.1055/a-2652-8941.

Mohamed SA, Apollos J, Anderson J, et al. British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland Guidance on Best Practice for Upper Gastrointestinal Endoscopy. Frontline Gastroenterology. Published online April 28, 2026. DOI: 10.1136/flgastro-2025-103455.

Dinis-Ribeiro M, Libânio D, Uchima H, et al. Management of Epithelial Precancerous Conditions and Early Neoplasia of the Stomach (MAPS III): European Society of Gastrointestinal Endoscopy, European Helicobacter and Microbiota Study Group, and European Society of Pathology Guideline Update 2025. Endoscopy. 2025;57(5):504–554. Published online March 20, 2025. DOI: 10.1055/a-2529-5025.

Nagula S, Parasa S, Laine L, Shah SC. AGA Clinical Practice Update on High-Quality Upper Endoscopy: Expert Review. Clinical Gastroenterology and Hepatology. 2024;22(5):933–943. DOI: 10.1016/j.cgh.2023.10.034.

National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026.

Government of Viet Nam. Decree No. 96/2023/ND-CP, detailing certain provisions of the Law on Medical Examination and Treatment, as amended where applicable.

Ministry of Health of Viet Nam. Circular No. 23/2024/TT-BYT, Promulgating the List of Medical Examination and Treatment Techniques. October 18, 2024, as subsequently amended.

Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT, Amending and Supplementing Certain Provisions of Ministry of Health Circulars, Including Circular No. 23/2024/TT-BYT. June 30, 2026. Article 3 amendments concerning the technique lists effective July 1, 2026; general effective date August 15, 2026.

Ministry of Health of Viet Nam. Consolidated Document No. 13/2026/VBHN-TT-BYT, Concerning the List of Medical Examination and Treatment Techniques. July 30, 2026.

Ministry of Health of Viet Nam. Circular No. 13/2025/TT-BYT, Providing Guidance on the Implementation of Electronic Medical Records in Healthcare Facilities. June 6, 2025. Effective July 21, 2025.

National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. Effective January 1, 2026.

Government of Viet Nam. Decree No. 356/2025/ND-CP, Detailing Certain Provisions and Measures for Implementing the Law on Personal Data Protection. Effective January 1, 2026.

Professional Scope and Disclaimer

This article is published by Diagnostic Excellence Vietnam (DxEx.vn), a professional initiative dedicated to advancing diagnostic quality, safety, and reliability in Viet Nam through evidence-informed knowledge sharing, risk management, measurement, and quality improvement.

The content is intended for general professional education and discussion. It does not constitute patient-specific medical advice, a clinical or endoscopic diagnosis, individualized instructions concerning upper gastrointestinal endoscopy, sedation, mucosal preparation, biopsy, surveillance, treatment or follow-up, a determination of professional or technical error, an accreditation assessment, or legal advice.

References to ESGE, BSG, AUGIS, AGA, and other international professional guidelines, quality measures, and recommendations do not imply that they are automatically mandatory under Vietnamese law. Their applicability depends on the clinical indication, procedural setting, relevant professional standards, authorized service capabilities, and applicable legal requirements.

Patient-specific decisions concerning endoscopy indications, preparation, procedural techniques, mucosal assessment, tissue sampling, interpretation, reporting, clinical follow-up, and treatment must be undertaken by appropriately qualified and authorized healthcare professionals in accordance with applicable Vietnamese law, relevant professional standards, validated institutional procedures, and the patient's clinical circumstances.

Diagnostic Excellence Vietnam does not provide endoscopic examinations, clinical diagnosis, or treatment services through this educational publication.